|Articles|September 12, 2016
Pfizer Taps Harvard's Ole Isacson as CSO of Neuroscience Research Unit
September 12, 2016
Advertisement
Pfizer has announced that Dr. Ole Isacson will become its Chief Scientific Officer of the Neuroscience Research Unit and Senior Vice President, effective September 16.
Dr. Isacson is a Professor of Neurology at Harvard Medical School, and will continue to serve in an educational role. He is also a founding director of the Neuroregeneration Institute at McLean Hospital.
Dr. Isacson will report directly to Mikael Dolsten, President of Worldwide Research and Development.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
3
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
4
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
5